PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapy.

Reni, M; Cereda, S; Mazza, E; Passoni, P; Nicoletti, R; Balzano, G; Zerbi, A; Arcidiacono, P G; Staudacher, C; Di Carlo, V

Reni, M; Cereda, S; Mazza, E; Passoni, P; Nicoletti, R; Balzano, G; Zerbi, A; Arcidiacono, P G; Staudacher, C; Di Carlo, V.

Affiliation

Reni M; Department of Oncology, S. Raffaele Scientific Institute, Milan, Italy. reni.michele@hsr.it

Am J Clin Oncol ; 31(2): 145-50, 2008 Apr.

Article in En | MEDLINE | ID: mdl-18391598

Subject(s)

Adenocarcinoma/drug therapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Pancreatic Neoplasms/drug therapy; Salvage Therapy; Adenocarcinoma/pathology; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cisplatin/administration & dosage; Cisplatin/adverse effects; Deoxycytidine/administration & dosage; Deoxycytidine/adverse effects; Deoxycytidine/analogs & derivatives; Drug-Related Side Effects and Adverse Reactions; Epirubicin/administration & dosage; Epirubicin/adverse effects; Female; Fluorouracil/administration & dosage; Fluorouracil/adverse effects; Humans; Male; Middle Aged; Pancreatic Neoplasms/pathology; Survival Analysis; Gemcitabine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy Type of study: Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Clin Oncol Year: 2008 Document type: Article Affiliation country: Italy Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google